Tools
Stock profile

Oscar Health, Inc. (OSCR)

OSCR · Latest close $27.57 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$27.57
As of Nov 18, 2026
Tracked funds holding
2 of 149
2026 Q2 13F filings
Opened / added
2 / 0
vs previous quarter
Trimmed / exited
1
vs previous quarter

Oscar Health, Inc. (OSCR) is held by 2 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 2 funds opening new positions and 1 fund trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $26.2M sold). Latest close $27.57 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Sep 18, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $-26.2M
Fundamentals
Revenue · FY2025
Red flags
screens flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Perceptive Advisors · Polen Capital Management — 2 tracked funds hold OSCR. See all holders.

Insider and Congress activity

Insiders bought on the open market (0 purchases, $0) vs 8 sales ($26.2M). Insider trading

Often held alongside

Elevance Health, Inc. (ELV) · Cigna Group (CI) · HUMANA INC (HUM) · CENTENE CORP (CNC) · MOLINA HEALTHCARE, INC. (MOH) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Perceptive Advisors0.17%400,000NEW Q3 filed Nov 16
Polen Capital Management0.01%38,701NEW Q3 filed Nov 13
Sessa Capital——EXITED

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: -6.5% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

35.199.882024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding406 of 8,857 filers
Long-only filers among them400
Change vs 2026 Q1+81 net · 387 entered · 306 exited
Shares reported, all filers197,978,103
Reported value, all filers$5.9B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustryHospital & Medical Service Plans (SIC 6324)
Revenue · FY2025$11.7B
Net income · FY2025$-443.2M
Total assets · FY2025$6.3B
Shares outstanding262,388,000
Market cap (at latest close)$7.2B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Dec 31, 2025.

Short interest

Shares short · Oct 15, 202618,294,074
Share of shares outstanding6.97%
Days to cover3.73

Shares short at recent settlements — Jul 31, 2026: 17.8M · Aug 14, 2026: 16.4M · Aug 31, 2026: 16.4M · Sep 15, 2026: 17.8M · Sep 30, 2026: 16.5M · Oct 15, 2026: 18.3M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Dec 31, 2025.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Dec 31, 2025.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 8 sales by 6 insiders ($26.2M).

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Sep 18, 2026WITTMAN VANESSA AMESSell25,000$32.24$806.0KSEC filing
Sep 3, 2026Baltrus VictoriaChief Accounting OfficerSell958$31.45$30.1KSEC filing
Sep 3, 2026Schlosser MarioSell31,422$31.45$988.2KSEC filing
Sep 3, 2026McAnaney AdamChief Legal OfficerSell9,092$31.45$285.9KSEC filing
Sep 3, 2026Liang JanetPresident, Oscar InsuranceSell10,360$31.45$325.8KSEC filing
Sep 3, 2026Blackley Richard ScottChief Financial OfficerSell28,869$31.45$907.9KSEC filing
Aug 28, 2026Schlosser MarioSell150,000$30.79$4.6MSEC filing
Aug 27, 2026Schlosser MarioSell600,000$30.34$18.2MSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Sep 18, 2026WITTMAN VANESSA AMESOfficer25,000$806.0KSep 18, 2026SEC filing
Sep 3, 2026McAnaney AdamOfficer9,092$285.9KSep 3, 2026SEC filing
Sep 3, 2026Schlosser MarioOfficer, Director31,422$988.2KSep 3, 2026SEC filing
Sep 3, 2026Liang JanetOfficer10,360$325.8KSep 3, 2026SEC filing
Sep 3, 2026Blackley Richard ScottOfficer28,869$908.0KSep 3, 2026SEC filing
Aug 28, 2026Schlosser MarioOfficer, Director150,000$4.6MAug 28, 2026SEC filing
Aug 27, 2026Schlosser MarioOfficer, Director600,000$18.2MAug 27, 2026SEC filing
Aug 20, 2026JEFFERY H. BOYDFormer Affiliate288,514$9.6MAug 20, 2026SEC filing
Aug 18, 2026Richard Scott BlackleyOfficer - CFO18,750$614.2KAug 18, 2026SEC filing
Aug 13, 2026JEFFERY H. BOYDFormer Affiliate288,513$8.7MAug 13, 2026SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

Activist disclosure · Schedule 13D

FiledFormPrice change since disclosure
Sep 18, 2026SCHEDULE 13D/A-4.6% (close Sep 21, 2026 → Nov 17, 2026)

Reference close is the first trading day after the filing (Sep 21, 2026). A Schedule 13D reports beneficial ownership, not a purchase — there is no transaction price to show. Source: SEC EDGAR Schedule 13D filings.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Sep 18, 2026Thrive Capital Partners II, L.P.SC 13D/A4,779,7301.7%Sep 18, 2026SEC filing
Mar 27, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Feb 17, 2026Marc StadSC 13G/A657,4350.3%Dec 31, 2025SEC filing
Nov 14, 2025T. Rowe Price Investment Management, Inc.SC 13G/A8,322,0043.7%Sep 30, 2025SEC filing
Nov 13, 2025Deerfield Mgmt, L.P.SC 13G/A00.0%Sep 30, 2025SEC filing
Jul 31, 2025JPMORGAN CHASE & CO.SC 13G/A9,950,7894.5%Jun 30, 2025SEC filing
Jul 17, 2025BlackRock, Inc.SC 13G/A13,941,7116.4%Jun 30, 2025SEC filing
Apr 29, 2025JPMORGAN CHASE & CO.SC 13G13,810,9236.4%Mar 31, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Hospital & Medical Service Plans (SIC 6324). Standing committees with jurisdiction over this industry: House Committee on Financial Services, Senate Committee on Banking, Housing, and Urban Affairs.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Screens & lenses

Financial Screens

· Growth — Revenue up every year for 5 straight years

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

Red Flags

· Distress Risk (Altman Z″) — Altman Z″-Score below 1.10

Key figures

· Growth — Latest revenue: $11.7B · 5-yr revenue CAGR: 90.8% · Straight growth years: 5

· Distress Risk (Altman Z″) — Z″-Score: -2.18 · Working capital / assets: -0.04 · Retained earnings / assets: -0.52 · EBIT / assets: -0.06 · Equity / liabilities: 0.18

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Insider BEST — appeared in 2 of the last 20 quarterly lists; latest 2024 Q4, ranked #25 of 50.

Also held by the tracked funds that hold OSCR — ranked by lift, the co-holding pattern described in Methodology: Elevance Health, Inc. (ELV) · Cigna Group (CI) · HUMANA INC (HUM) · CENTENE CORP (CNC) · MOLINA HEALTHCARE, INC. (MOH) · TRUPANION, INC. (TRUP) · PROGRESSIVE CORP/OH/ (PGR) · Chubb Ltd (CB).

8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Nov 16, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain OfficersSEC filing
Nov 5, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Sep 16, 20267.01 Regulation FD DisclosureSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

Elevance Health, Inc. (ELV) · Track Record: how the signals scored · Practice timing on OSCR

One email a week: the week’s new filings and research. Subscribe free

← ORN  ·  OSG →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.